MARTELLI, Massimo Fabrizio
 Distribuzione geografica
Continente #
NA - Nord America 6.132
EU - Europa 4.809
AS - Asia 1.765
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 7
AF - Africa 3
OC - Oceania 3
Totale 12.728
Nazione #
US - Stati Uniti d'America 6.118
UA - Ucraina 1.128
IE - Irlanda 1.058
SE - Svezia 833
SG - Singapore 652
IT - Italia 566
HK - Hong Kong 448
DE - Germania 310
FI - Finlandia 301
CN - Cina 298
VN - Vietnam 215
RU - Federazione Russa 194
GB - Regno Unito 158
KR - Corea 57
BE - Belgio 52
FR - Francia 37
TR - Turchia 34
CZ - Repubblica Ceca 32
CH - Svizzera 28
AT - Austria 24
UZ - Uzbekistan 23
NL - Olanda 22
GR - Grecia 15
PL - Polonia 15
RO - Romania 13
CA - Canada 12
IN - India 9
EU - Europa 7
IL - Israele 7
BG - Bulgaria 5
LB - Libano 5
AU - Australia 3
BR - Brasile 3
ES - Italia 3
PT - Portogallo 3
AM - Armenia 2
AZ - Azerbaigian 2
DK - Danimarca 2
EC - Ecuador 2
EE - Estonia 2
GE - Georgia 2
HR - Croazia 2
KG - Kirghizistan 2
LT - Lituania 2
LV - Lettonia 2
PE - Perù 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BD - Bangladesh 1
BO - Bolivia 1
GH - Ghana 1
GT - Guatemala 1
ID - Indonesia 1
IM - Isola di Man 1
LK - Sri Lanka 1
MA - Marocco 1
MX - Messico 1
PH - Filippine 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
ZA - Sudafrica 1
Totale 12.728
Città #
Chandler 1.232
Dublin 1.058
San Mateo 670
Jacksonville 631
Singapore 530
Hong Kong 446
Boardman 396
Ann Arbor 304
Santa Clara 261
Medford 226
Princeton 224
Dong Ket 215
Altamura 191
Wilmington 163
Andover 161
Perugia 152
Lawrence 140
Beijing 126
Helsinki 77
Ashburn 74
Woodbridge 63
Saint Petersburg 62
Norwalk 53
Seoul 52
Brussels 49
New York 42
Des Moines 40
Los Angeles 40
Shanghai 40
Houston 38
Munich 36
Dearborn 34
Izmir 32
San Paolo di Civitate 32
Auburn Hills 26
Brno 23
Redwood City 20
Dallas 19
Foligno 17
San Diego 14
Espoo 12
Falls Church 12
Moscow 12
Redmond 12
Florence 10
Milan 10
Groningen 9
Rome 9
Bucharest 8
West Jordan 8
Den Haag 6
Padova 6
Renton 6
Simi Valley 6
Terni 6
Bologna 5
Chicago 5
Guangzhou 5
London 5
Marsciano 5
Ottawa 5
Amsterdam 4
Kiryat Ono 4
Ancona 3
Bengaluru 3
Edinburgh 3
Hangzhou 3
Hanover 3
Hefei 3
Madrid 3
Mirano 3
Nanning 3
Nuremberg 3
Nürnberg 3
Philadelphia 3
Prague 3
Tavernelle 3
Tel Aviv 3
Vigodarzere 3
Zaventem 3
Aigaleo 2
Baku 2
Bishkek 2
Brescia 2
Bupyeong-gu 2
Cambridge 2
Eunpyeong-gu 2
Frankfurt am Main 2
Gualdo Tadino 2
Lausanne 2
Lima 2
Lisbon 2
Ludwigshafen 2
Manchester 2
Montréal 2
Naples 2
New Haven 2
Oklahoma City 2
Paris 2
Parma 2
Totale 8.270
Nome #
Advances in full-haplotype mismatched transplants in acute leukemia 128
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment. 116
Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML. 115
Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction 109
Innate immunity against hematological malignancies 106
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment in vitro and supports immunologic reconstitution after HSCT in NOD/SCID mice 98
Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification 97
Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biological and clinical features 96
Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self. 93
Mesenchymal cells: a vehicle for gene therapy 92
Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation 92
14q+ chromosome marker in a T-cell-rich B-cell lymphoma. 91
Regions of juxtaposition in unbalanced 1q rearrangements of malignant hemopathies 89
Graft engineering for allogeneic haploidentical stem cell transplantation 88
Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias. 86
Anti-CD30 (BER=H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice. 86
e6a2 BCR/ABL1 fusion with cryptic der(9)t(9;22) deletions in a patient with chronic myeloid leukemia 86
A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation. 84
Acute lymphoblastic leukaemia in Noonan syndrome 84
Fourth international workshop on haploidentical transplants, Naples, Italy 83
Comparison of immunosuppressive effects of single-dose and hyperfractionated total body irradiation 83
Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation. 80
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 80
. G-CSF blocks IL-12 productin by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation. 79
MONOCLONAL ANTIBODIES PG-B6a AND PG-B6p RECOGNIZE, RESPECTIVELY, A HIGHLY CONSERVED AND A FORMOL-RESISTANT EPITOPE ON THE HUMAN BCL-6 PROTEIN AMINO-TERMINAL REGION. 79
NPM1 deletion is associated with gross chromosomal rearrangements in leukemia 79
Increasing the Astrophysical Reach of the Advanced Virgo Detector via the Application of Squeezed Vacuum States of Light 79
t(3;11)(q12;p15)/NUP98-LOC348801 fusion transcript in acute myeloid leukemia 78
G-CSF blocks IL-12 production by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation.. 77
3q aberration and monosomy 7 in ANLL presenting with high platelet count and diabetes insipidus. 76
A common 93-kb duplicated DNA sequence at 1q21.2 in acute lymphoblastic leukemia and Burkitt lymphoma 76
FIP1L1-PDGFRA in chronic eosinophilic leukemia and BCR-ABL1 in chronic myeloid leukemia affect different leukemic cells 75
Haploidentical stem cell transplantation for acute leukemia 74
New perspectives in haematopoietic stem cell transplantation. Transplantation across HLA barriers. 74
A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation. 74
Engineering mesenchymal cells with interleukin 7 gene: effects on T cell. 18-23. 74
Clinical-Grade Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell Dependent Graft-versus-Leukemia Effect in Murine Models 74
Transplants across human leukocyte antigen barriers 73
Raccolta dei progenitori emopoietici circolanti allogenici con separatore cellulare a flusso discontinuo. . 73
Hematopoietic stem cell transplantation from alternative sources in adults with high-risk acute leukemia. 73
A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1) 73
Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. 72
Natural killer cell alloreactivity in allogeneic hematopoietic transplantation. 71
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality 71
Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse 71
The in vivo effect of thymic factor (thymostimulin) administration in Hodgkin's disease patients. Correlation of skin reactivity and leukocyte migration-inhibition factor in the sera of anergic subjects 70
Human stromal cells engineered with interleukin-7 enhance the survival of naive T lymphocytes. 69
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. 69
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. 69
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia 68
Prevalence, incidence and clinical outcome of hepatitis B virus and hepatitis C virus hepatitis in patients undergoing allogeneic hematopoietic stem cell transplantation between 2001 and 2004. 68
The hypereosinophilic syndrome: fluorescence in situ hybridization detects the del(4)(q12)-FIP1L1/PDGFRA but not genomic rearrangements of other tyrosine kinases 68
AML1/MTG16 fusion gene from a t(16;21)(q24;q22) translocation in treatment-induced leukemia after breast cancer 68
Haploidentical transplantation and natural killer cell recognition of missing self. 67
5q- syndrome in a patient with chronic exposure to ionizing radiation. 67
T regulatory cell separation for clinical application. 67
The role of megadose CD34+ progenitor cells in the treatment of leukemia patients without a matched donor and in tolerance induction for organ transplantation. . 66
Exon-12 nucleophosmin (NPM) mutation and aberrant cytoplasmic expression of NPM protein in leukemia cell line OCI-AML3 66
Cytogenetic and FISH investigations on Tetrasomy 8 in ALL. 66
Natural killer cell alloreactivity for leukemia therapy. 66
Immunotherapy with alloreactive natural killer cells in haploidentical haematopoietic transplantation. 65
Aberrant cytoplasmic expression of C-terminal-truncated NPM leukaemic mutant is dictated by tryptophans loss and a new NES motif. 65
A NUP98-positive acute myeloid leukemia with a t(11;12)(p15;q13) without HOXC cluster gene involvement 65
"Designed" grafts for HLA-haploidentical stem cell transplantation. 65
How Adoptive Immunotherapy with Conventional T and Regulatory T Cells Exerts a Gvl Effect without GvHD, after Haploidentical Hematopoietic Transplantation 65
Full-haplotype mismatched HSCT for high risk acute myeloid leukemia (AML). 65
Combined interphase fluorescence in situ hybridization elucidates the genetic heterogeneity of T-cell acute lymphoblastic leukemia in adults 64
Optimizing a photoallodepletion protocol for adoptive immunotherapy after haploidentical SCT. 64
Cellular therapy: exploiting NK cell alloreactivity in transplantation 63
A western blot assay for detecting mutant nucleophosmin (NPM1) proteins in acute myeloid leukaemia. 63
Dual-color split signal fluorescence in situ hybridization assays for the detection of CALM/AF10 in t(10;11)(p13;q14-q21)-positive acute leukemia 63
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants 63
null 63
null 63
Stem cell mobilization in normal donors. 62
Decreased bone mineral density after autologous stem cell transplantation. 62
5q- syndrome termi¬nating in acute myeloid leukemia: karyotype evolution and immunological characterization of blast cells. 62
Born to be exported: COOH-terminal nuclear export signals of different strength ensure cytoplasmic accumulation of nucleophosmin leukemic mutants 62
Total Marrow/Total Lymphoid Irradiation as Conditioning for Haploidentical Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patients 62
Clinical impact of natural killer cell reconstitution after allogenic hematopoitic transplantation.Immunobiology working Party of the European Group for Blood and Marrow Transplantation 62
Natural killer cell alloreactivity and haplo-identical hematopoietic transplantation. 61
Hematopoietic stem cell transplantation (HSCT) from alternative donors for acute leukemia at high-risk of relapse. the haploidentical option. 61
Cryptic insertion producing two NUP98/NSD1 chimeric transcripts in adult refractory anemia with an excess of blasts 61
Molecular cytogenetic findings in a four-way t(1;12;5;12)(p36;p13;q33;q24) underlying the ETV6-PDGFRB fusion gene in chronic myelomonocytic leukemia 61
CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice. 61
Allogeneic transplantation across the HLA barriers. 61
Defective antifungal T-helper 1 (TH1) immunity in a murine model of allogeneic T-cell-depleted bone marrow transplantation and its restoration by treatment with TH2 cytokine antagonists. 60
Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): a comparison with NPMc+ AML. 60
Mechanism of altered nucleo-cytoplasmic traffic of nucleophosmin in acute myelogenous leukemia carrying exon12 NPM mutations (NPMc plus AML) 60
Donor activating KIR genes and control of infections after haploidentical haematopoietic transplantation 60
Hematopoietic Stem Cell Transplantation across Major Genetic Barriers: Tolerance Induction by Megadose CD34 Cells and Other Veto Cells. 59
Cellular localization and tissue distribution of PML proteins as defined by a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product. Preferential expression in postmitotic cells. 59
Cytoplasmic nucleophosmin in myeloid sarcoma occurring 20 years after diagnosis of acute myeloid leukaemia 59
Full haplotype mismatched transplant in high risk acute leukemia patients. 58
Gli anticorpi monoclonali nella terapia delle emopatie maligne. 58
Totipotent stem cells bearing del(20q) maintain multipotential differentiation in Shwachman Diamond syndrome 58
A simple prognostic scoring system for newly diagnosed cytogenetically normal acute myeloid leukemia: retrospective analysis of 530 patients 58
A PDGFRB-positive acute myeloid malignancy with a new t(5;12)(q33;p13.3) involving the ERC1 gene 58
Different genomic imbalances in low- and high-grade HCV-related lymphomas 57
NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL. 57
Totale 7.276
Categoria #
all - tutte 55.049
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.049


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020742 0 0 0 0 0 32 181 14 179 112 34 190
2020/20212.209 20 166 96 174 587 142 198 12 249 91 220 254
2021/20222.169 55 525 71 175 94 11 30 620 18 39 266 265
2022/20233.658 253 631 26 336 276 384 4 200 1.391 12 113 32
2023/20241.503 85 156 64 31 10 20 320 43 197 40 251 286
2024/20251.318 93 347 136 156 446 140 0 0 0 0 0 0
Totale 13.191